Monday May 17, 9:08 am Eastern Time
Company Press Release
Scottsdale Scientific Announces Prestigious Invitation
to the 10th International Congress of Medical Results
on Ortho-Biomolecular, Nutrition and Functional
Medicine
Chairman of the Board, Dr. Stephen Levine, will be the Keynote Speaker to over 400 Medical
Doctors from Around the World
SCOTTSDALE, Ariz.--(BW HealthWire)--May 17, 1999-- Scottsdale Scientific, Inc. (Symbol:STDS), through its wholly owned
subsidiary NutriCology, Inc., is honored to be invited to this prestigious world event to be held in Sao Paulo, Brazil, June 25th -
28th, 1999.
Chairman of the Board, Head of Research and Development, Dr. Stephen Levine, will be the Keynote Speaker to over 400
medical doctors worldwide attending this conference.
Roberto Mattos, President of Sao Paulo based Aplacom, states, ''We are very honored to have Dr. Levine in attendance. His
book on the role of antioxidants is recognized in Brazil and elsewhere as the premier reference in this category. Dr. Levine's
international stature and presence at this event raises the level and visibility of the widespread acceptance of supplements by
traditional caregivers.''
Aplacom is the exclusive distributor of Scottsdale Scientific's product line throughout Brazil and South America. Aplacom, which
was established in 1984, distributes nutritional supplements to biochemists, pharmacists, nutritionists and medical doctors, including
endocrinologists, gynecologists and immunologists. Aplacom's total sales from 1998 have increased 26% over 1997 and Scottsdale
Scientific's sales from this distribution agreement have increased 25% from 1997 to 1998. Futhermore, Aplacom's recently
established banking agreement with Bradesco (Brazil's major retail bank) is facilitating the Company's expansion.
Marianne Sum, President and CEO of Scottsdale Scientific, comments, ''It is very satisfying to see the growth and commitment
exhibited by Mr. Mattos at Aplacom. Our relationship has grown significantly this past year and despite a rocky South American
economic condition, Aplacom has met their commitments and secured the proper financial instruments to protect themselves and
our Company while continuing to grow.''
Scottsdale Scientific, Inc., through its wholly owned subsidiary, NutriCology, Inc. is an innovative leader in nutraceutical research
and product formulation. Since 1979, the Company is noted for quality, hypoallergenic nutritional supplements and supplies
products to approximately 6,000 physicians and health care practitioners worldwide. Allergy Research Group was the first in the
U.S. to introduce numerous specialty products including melatonin, a neurohormone, germanium sesquioxide (a trace mineral),
AntiOx(tm), a broad-spectrum antioxidant, Buffered Vitamin C and the Total Nutrient Concept. (Includes all in one, proprietary
formulas, Total Immune(tm), Total Nerve(tm) and Total Heart(tm)).
For additional information, visit our web site at www.nutricology.com
Disclaimer: This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of
1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance
and underlying assumptions and other statements, which are other than statements of historical facts. These statements are
subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology,
economic conditions, the impact of competition and pricing, government regulation, and other risks defined in this document and in
statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether
written or oral, and whether made by or on behalf of the Company are expressly qualified by these cautionary statements and any
other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any
obligation to update any forward-looking statements to reflect events or circumstances after the date hereof. |
